デフォルト表紙
市場調査レポート
商品コード
1547709

肺機能検査システムの世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Pulmonary Function Testing Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032


出版日
ページ情報
英文 332 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
肺機能検査システムの世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 332 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

肺機能検査システム市場の世界需要は、2023年の27億8,000万米ドルから2032年には50億7,000万米ドル近くの市場規模に達すると推定され、調査期間2024~2032年のCAGRは6.91%です。

肺機能検査は、肺機能検査としても知られ、喘息、呼吸器感染症、慢性閉塞性肺疾患(COPD)などの肺疾患の診断に使用されます。肺機能検査(PFT)は非侵襲的な検査であり、肺の機能と呼吸能力を測定し、感染のないことを確認します。このプロセスは、胸部X線検査、身体検査、動脈血ガス分析、患者の生活習慣や健康歴の調査などを通じて、患者の肺の健康状態を正確に調べることからなります。

市場力学

COPD、喘息などの肺疾患の優位性の高まり、肺機能検査装置の利用可能性、肺機能検査に対する需要の高まりは、市場の成長を刺激する重要な要因です。肺機能検査における技術の進歩や高齢者人口の増加も市場成長に影響を与えています。ライフスタイルの変化や喫煙中毒は、肺がんのようないくつかの肺の問題を引き起こし、市場の成長をさらに促進します。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、肺機能検査システムの世界市場における各セグメントを包括的に評価することもできます。肺機能検査システム産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

肺機能検査システム市場レポートのこのセクションでは、国別と地域別のセグメントに関する詳細なデータを提供し、それによって戦略家が今後の機会とともに、それぞれの製品やサービスの対象層を特定するのに役立ちます。

地域別分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける肺機能検査システム市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、すべての主要地域における個々の用途セグメントの需要、推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 肺機能検査システム-産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 肺機能検査システムの世界市場分析:製品タイプ別

  • 製品タイプ別概要
  • 製品タイプ別過去・予測データ分析
  • ハンドヘルド型
  • 卓上型

第6章 肺機能検査システムの世界市場分析:検査タイプ別

  • 検査タイプ別概要
  • 検査タイプ別過去・予測データ分析
  • スパイロメトリー
  • 肺活量検査
  • ガス拡散検査
  • 運動負荷検査
  • 高所シミュレーション検査
  • その他

第7章 肺機能検査システムの世界市場分析:用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • 慢性閉塞性肺疾患
  • 喘息
  • 慢性息切れ
  • 肺線維症
  • その他

第8章 肺機能検査システムの世界市場分析:流通チャネル別

  • 流通チャネル別概要
  • 流通チャネル別過去・予測データ分析
  • 病院・クリニック薬局
  • 実店舗
  • eコマース

第9章 肺機能検査システムの世界市場分析:最終用途別

  • 最終用途別概要
  • 最終用途別過去・予測データ分析
  • 病院とクリニック
  • 診断センター
  • 在宅医療
  • その他

第10章 肺機能検査システムの世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋:セグメント別
    • アジア太平洋:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第11章 肺機能検査システム企業の競合情勢

  • 肺機能検査システム市場競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Koninklijke Philips N.V.
  • Medical Equipment Europe
  • Medtronic
  • Minato Holdings Inc
  • Morgan Scientific Inc.
  • Ndd Medizintechnik AG
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (Units and USD MN)
  • Handheld Market Sales By Geography (Units and USD MN)
  • Tabletop Market Sales By Geography (Units and USD MN)
  • Analysis By Test Type (Units and USD MN)
  • Spirometry Market Sales By Geography (Units and USD MN)
  • Lung Volume Test Market Sales By Geography (Units and USD MN)
  • Gas Diffusion Test Market Sales By Geography (Units and USD MN)
  • Exercise Stress Test Market Sales By Geography (Units and USD MN)
  • High Altitude Simulation Testing Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Analysis By Application (Units and USD MN)
  • Chronic Obstructive Pulmonary Disease Market Sales By Geography (Units and USD MN)
  • Asthma Market Sales By Geography (Units and USD MN)
  • Chronic Shortness of Breath Market Sales By Geography (Units and USD MN)
  • Pulmonary Fibrosis Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Analysis By Distribution Channel (Units and USD MN)
  • Hospital & Clinics Pharmacies Market Sales By Geography (Units and USD MN)
  • Brick & Mortar Market Sales By Geography (Units and USD MN)
  • E-Commerce Market Sales By Geography (Units and USD MN)
  • Analysis By End-Use (Units and USD MN)
  • Hospitals & Clinics Market Sales By Geography (Units and USD MN)
  • Diagnostic Centers Market Sales By Geography (Units and USD MN)
  • Homecare Settings Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Pulmonary Function Testing Systems Market Sales By Geography (Units and USD MN)
  • North America Market Analysis (Units and USD MN)
  • United States Market Analysis (Units and USD MN)
  • Canada Market Analysis (Units and USD MN)
  • Mexico Market Analysis (Units and USD MN)
  • Europe Market Analysis (Units and USD MN)
  • Europe Market Estimate By Country (Units and USD MN)
  • United Kingdom Market Analysis (Units and USD MN)
  • France Market Analysis (Units and USD MN)
  • Germany Market Analysis (Units and USD MN)
  • Italy Market Analysis (Units and USD MN)
  • Russia Market Analysis (Units and USD MN)
  • Spain Market Analysis (Units and USD MN)
  • Rest of Europe Market Analysis (Units and USD MN)
  • Asia Pacific Market Analysis (Units and USD MN)
  • China Market Analysis (Units and USD MN)
  • Japan Market Analysis (Units and USD MN)
  • India Market Analysis (Units and USD MN)
  • South Korea Market Analysis (Units and USD MN)
  • Australia Market Analysis (Units and USD MN)
  • South East Asia Market Analysis (Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Units and USD MN)
  • Latin America Market Analysis (Units and USD MN)
  • Brazil Market Analysis (Units and USD MN)
  • Argentina Market Analysis (Units and USD MN)
  • Peru Market Analysis (Units and USD MN)
  • Chile Market Analysis (Units and USD MN)
  • Rest of Latin America Market Analysis (Units and USD MN)
  • Middle East & Africa Market Analysis (Units and USD MN)
  • Saudi Arabia Market Analysis (Units and USD MN)
  • UAE Market Analysis (Units and USD MN)
  • Israel Market Analysis (Units and USD MN)
  • South Africa Market Analysis (Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Pulmonary Function Testing Systems Report
  • Market Research Process
  • Market Research Methodology
  • Global Pulmonary Function Testing Systems Market Size, By Region (Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Test Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (Units and USD MN)
  • Handheld Market Sales By Geography (Units and USD MN)
  • Tabletop Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Test Type (Units and USD MN)
  • Spirometry Market Sales By Geography (Units and USD MN)
  • Lung Volume Test Market Sales By Geography (Units and USD MN)
  • Gas Diffusion Test Market Sales By Geography (Units and USD MN)
  • Exercise Stress Test Market Sales By Geography (Units and USD MN)
  • High Altitude Simulation Testing Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Application (Units and USD MN)
  • Chronic Obstructive Pulmonary Disease Market Sales By Geography (Units and USD MN)
  • Asthma Market Sales By Geography (Units and USD MN)
  • Chronic Shortness of Breath Market Sales By Geography (Units and USD MN)
  • Pulmonary Fibrosis Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Distribution Channel (Units and USD MN)
  • Hospital & Clinics Pharmacies Market Sales By Geography (Units and USD MN)
  • Brick & Mortar Market Sales By Geography (Units and USD MN)
  • E-Commerce Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By End-Use (Units and USD MN)
  • Hospitals & Clinics Market Sales By Geography (Units and USD MN)
  • Diagnostic Centers Market Sales By Geography (Units and USD MN)
  • Homecare Settings Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Market Sales (Units and USD MN)
  • North America Market Sales (Units and USD MN)
  • Europe Market Sales (Units and USD MN)
  • Asia Pacific Market Sales (Units and USD MN)
  • Latin America Market Sales (Units and USD MN)
  • Middle East & Africa Market Sales (Units and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11213751

The global demand for Pulmonary Function Testing Systems Market is presumed to reach the market size of nearly USD 5.07 Billion by 2032 from USD 2.78 Billion in 2023 with a CAGR of 6.91% under the study period 2024-2032.

Pulmonary function test, also known as Lung function tests, is used to diagnose lung disorders such as asthma, respiratory infections, chronic obstructive pulmonary disease (COPD), and others. Pulmonary function tests (PFTs) are noninvasive tests and determine the lungs' functioning and the ability of a person to breathe and make sure about infection-free. The process consists of a precise examination of the patient's pulmonary health over chest x-rays, physical tests, arterial blood gas analysis, and a study of the patient's habits and health history.

MARKET DYNAMICS

The rising predominance of lung diseases such as COPD, asthma, and others, availability of lung function test devices, and rising demand for lung function tests are significant factors stimulating the growth of the market. Technological advancements in lung testing and the increasing geriatric population are also influencing the market growth. Changing lifestyle and smoking addiction leads to several lung problems such as lung cancer, which further drives the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Pulmonary Function Testing Systems. The growth and trends of Pulmonary Function Testing Systems industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Pulmonary Function Testing Systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Handheld
  • Tabletop

By Test Type

  • Spirometry
  • Lung Volume Test
  • Gas Diffusion Test
  • Exercise Stress Test
  • High Altitude Simulation Testing
  • Others

By Application

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Chronic Shortness of Breath
  • Pulmonary Fibrosis
  • Others

By Distribution Channel

  • Hospital & Clinics Pharmacies
  • Brick & Mortar
  • E-Commerce

By End-Use

  • Hospitals & Clinics
  • Diagnostic Centers
  • Homecare Settings
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pulmonary Function Testing Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pulmonary Function Testing Systems market include Koninklijke Philips N.V., Medical Equipment Europe, Medtronic, Minato Holdings Inc, Morgan Scientific Inc., Ndd Medizintechnik AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PULMONARY FUNCTION TESTING SYSTEMS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Test Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By End-Use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Handheld Historic and Forecast Sales By Regions
  • 5.4. Tabletop Historic and Forecast Sales By Regions

6. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY TEST TYPE

  • 6.1. Overview By Test Type
  • 6.2. Historical and Forecast Data Analysis By Test Type
  • 6.3. Spirometry Historic and Forecast Sales By Regions
  • 6.4. Lung Volume Test Historic and Forecast Sales By Regions
  • 6.5. Gas Diffusion Test Historic and Forecast Sales By Regions
  • 6.6. Exercise Stress Test Historic and Forecast Sales By Regions
  • 6.7. High Altitude Simulation Testing Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Chronic Obstructive Pulmonary Disease Historic and Forecast Sales By Regions
  • 7.4. Asthma Historic and Forecast Sales By Regions
  • 7.5. Chronic Shortness of Breath Historic and Forecast Sales By Regions
  • 7.6. Pulmonary Fibrosis Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Hospital & Clinics Pharmacies Historic and Forecast Sales By Regions
  • 8.4. Brick & Mortar Historic and Forecast Sales By Regions
  • 8.5. E-Commerce Historic and Forecast Sales By Regions

9. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-Use
  • 9.2. Historical and Forecast Data Analysis By End-Use
  • 9.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 9.4. Diagnostic Centers Historic and Forecast Sales By Regions
  • 9.5. Homecare Settings Historic and Forecast Sales By Regions
  • 9.6. Others Historic and Forecast Sales By Regions

10. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE PULMONARY FUNCTION TESTING SYSTEMS COMPANIES

  • 11.1. Pulmonary Function Testing Systems Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF PULMONARY FUNCTION TESTING SYSTEMS INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Koninklijke Philips N.V.
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Medical Equipment Europe
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Medtronic
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Minato Holdings Inc
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Morgan Scientific Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Ndd Medizintechnik AG
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies